Finance

Vermont becomes first state to make oil companies pay for climate-change damage after Republican governor doesn’t veto bill

Vermont has become the first state to enact a law requiring fossil fuel companies to pay a share of the damage caused by...

How we made it work

"Your husband does what?!" I heard this question so many times over the 10 years my husband, Ian, flew weekly from our home...

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in...

An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25  were evaluable for efficacySYS6002 (CRB-701)...

Tech stocks to buy like Apple and Nvidia

Further upside is in the cards for a slate of stocks, including Nvidia , according to Bank of America. The firm recently called...

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity...

Bitcoin investors see sideways trading in June as focus turns to Washington

Markets are nearing the official start of summer, but bitcoin may languish in June. The flagship cryptocurrency jumped 13% in May, according to...

Activist Elliott wants Texas Instruments to boost free cash flow

The Texas Instruments Inc. logo is seen on scientific calculator packages in Tiskilwa, Illinois.Daniel Acker | Bloomberg | Getty ImagesCompany: Texas Instruments (TXN)Business:...

How America’s richest self-made woman went from debt to billionaire

At age 10, Diane Hendricks decided she wanted to work in the business world. It took years to achieve that goal, and decades...

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

-   WTX-124 was shown to be clinically active and generally well-tolerated in patients who were relapsed/refractory to immune checkpoint inhibitor therapy -...

Latest articles

spot_imgspot_img